Skip to main content
Caplight Logo









LinkoCare Life Sciences

LinkoCare Life Sciences

Private
LinköpingHealthcare & Life Scienceshttps://www.linkocare.com/

Last Round

Grant

Jul 12, 2024

Total Funding Raised

$1.7M

Company Overview

LinkoCare Life Sciences is a biotechnology company that develops and manufactures bioengineered corneal implants to treat corneal blindness and vision impairment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

corneal implantbioengineeringbiomaterialstissue engineeringadvanced therapy medicinal productsATMPporcine collagenophthalmologysight restorationartificial corneamedical devicein vitro modelsregenerative medicinecorneal blindnessbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LinkoCare Life Sciences Comparables

Compare LinkoCare Life Sciences with similar companies based on industry and business-model similarity.

LinkoCare Life Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CorNeat Vision
89%
EyeYon Medical
87%
KeraMed, Inc.
87%

LinkoCare Life Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 12, 2024
GrantDec 1, 2021
GrantNov 15, 2018
GrantNov 1, 2015
AcceleratorMar 2, 2015

Key People

Founding team and executive leadership

Mehrdad Rafat

Founder & CEO

Founding Team

Shideh Tabe

CFO & HR Manager

Executive Team

LinkoCare Life Sciences Investors

Notable investors and investment history

LinkoCare Life Sciences investors
InvestorRounds
European Institute of Innovation and TechnologyGrant
EIT HealthGrant
LEADAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors grew 68% MoM.

  • Jul 12, 2024

    Received grant funding.

LinkoCare Life Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LinkoCare Life Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LinkoCare Life Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersLinköping
Employee Range9
Year Founded2013
Last FundingJul 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?